We are live on ! Find out more
EOJOAM

E. Ohman J:or Asset Management Portfolio holdings

AUM $4.3B
1-Year Est. Return 29.55%
This Fund
S&P 500
This Quarter Est. Return
+22.53%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$4.3B
AUM Growth
+$519M
Cap. Flow
-$26.3M
Cap. Flow %
-0.61%
Top 10 Hldgs %
43.48%
Holding
487
New
10
Increased
143
Reduced
81
Closed
22
Avg Time Held
20.8 quarters
Top 10 Avg Time Held
24 quarters
Top 20 Avg Time Held
16.2 quarters

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$38.6M
2
SYK icon
Stryker
SYK
+$37.7M
3
COF icon
Capital One
COF
+$33.6M
4
DOV icon
Dover
DOV
+$31M
5
RDNT icon
RadNet
RDNT
+$23.4M

Top Sells

Rank Stock Value
1
CBOE icon
Cboe Global Markets
CBOE
+$56.7M
2
GILD icon
Gilead Sciences
GILD
+$44.4M
3
T icon
AT&T
T
+$34.8M
4
INTU icon
Intuit
INTU
+$32.5M
5
BSX icon
Boston Scientific
BSX
+$29.4M

Sector Composition

Rank Sector Weight
1 Technology 43.83%
2 Financials 13.15%
3 Healthcare 10.01%
4 Communication Services 9.79%
5 Consumer Discretionary 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CHRW icon
301
C.H. Robinson
CHRW
$16.1B
$970K 0.02%
5,150
– –
2013 Q2
52 quarters
GEHC icon
302
GE HealthCare
GEHC
$30.9B
$961K 0.02%
15,021
– –
2023 Q3
11 quarters
HBAN icon
303
Huntington Bancshares
HBAN
$30.5B
$950K 0.02%
53,600
-5,200
-9% -$85.8K
2014 Q4
46 quarters
PAYX icon
304
Paychex
PAYX
$38.3B
$944K 0.02%
9,600
-1,200
-11% -$114K
2022 Q2
16 quarters
XYL icon
305
Xylem
XYL
$23.9B
$943K 0.02%
7,980
– –
2013 Q2
52 quarters
EXPD icon
306
Expeditors International
EXPD
$25.4B
$940K 0.02%
5,767
+1,000
+21% +$155K
2013 Q2
52 quarters
SYF icon
307
Synchrony
SYF
$23.3B
$934K 0.02%
12,284
– –
2019 Q4
26 quarters
EXPE icon
308
Expedia Group
EXPE
$32.7B
$922K 0.02%
3,605
– –
2025 Q4
2 quarters
OTIS icon
309
Otis Worldwide
OTIS
$26.2B
$922K 0.02%
12,877
– –
2020 Q4
22 quarters
FISV icon
310
Fiserv Inc
FISV
$24.4B
$921K 0.02%
18,781
– –
2019 Q4
26 quarters
MDB icon
311
MongoDB
MDB
$29.5B
$920K 0.02%
2,739
– –
2025 Q1
5 quarters
DLTR icon
312
Dollar Tree
DLTR
$22.2B
$919K 0.02%
7,600
– –
2023 Q1
13 quarters
LYV icon
313
Live Nation Entertainment
LYV
$39.4B
$916K 0.02%
5,000
+400
+9% +$65.8K
2025 Q2
4 quarters
RJF icon
314
Raymond James Financial
RJF
$30B
$915K 0.02%
6,017
– –
2024 Q1
9 quarters
TROW icon
315
T. Rowe Price
TROW
$21.3B
$910K 0.02%
8,003
+1,400
+21% +$143K
2013 Q2
52 quarters
JBL icon
316
Jabil
JBL
$31.1B
$905K 0.02%
2,349
-1,450
-38% -$501K
2025 Q4
2 quarters
ILMN icon
317
Illumina
ILMN
$40.5B
$894K 0.02%
5,084
– –
2013 Q2
52 quarters
ENTG icon
318
Entegris
ENTG
$23.3B
$887K 0.02%
4,931
– –
2021 Q4
18 quarters
NTRA icon
319
Natera
NTRA
$57.5B
$877K 0.02%
3,232
-24,163
-88% -$5.15M
2023 Q1
13 quarters
WDAY icon
320
Workday
WDAY
$44.8B
$873K 0.02%
7,130
– –
2013 Q4
50 quarters
P icon
321
Everpure Inc
P
$48.5B
$868K 0.02%
11,015
– –
2025 Q4
2 quarters
ARES icon
322
Ares Management
ARES
$25.5B
$863K 0.02%
7,757
– –
2024 Q4
6 quarters
TWST icon
323
Twist Bioscience
TWST
$10B
$853K 0.02%
+8,287
New +$539K
2026 Q2
0 quarters
CBOE icon
324
Cboe Global Markets
CBOE
$31.6B
$853K 0.02%
3,513
-185,364
-98% -$56.7M
2019 Q4
26 quarters
SNA icon
325
Snap-on
SNA
$18.7B
$849K 0.02%
2,110
+700
+50% +$265K
2021 Q2
20 quarters
11 12
13
14 15

Similar funds

AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.3B AUM 24.01% 1-Year Est. Return
GHC
Great Hill Capital New York $4.29B AUM 18.17% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
DWM
Destination Wealth Management Walnut Creek, California $4.28B AUM 19.27% 1-Year Est. Return
HCC
Hill City Capital Boston, Massachusetts $4.28B AUM 80.76% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $4.28B AUM 43.07% 1-Year Est. Return

E. Ohman J:or Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, E. Ohman J:or Asset Management held 487 positions worth $4.3B, up 14% from $3.78B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

E. Ohman J:or Asset Management's Q2 2026 filing shows 10 new, 143 increased, 81 reduced and 22 closed positions. Its largest new stake was Denali Therapeutics: 160,000 shares worth $4.12M. The largest sale was Cboe Global Markets, an estimated $56.7M.

By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 42% a quarter earlier, followed by Financials and Healthcare.

  • E. Ohman J:or Asset Management's largest Q2 2026 buy was Denali Therapeutics: 160,000 shares worth $4.12M.
  • E. Ohman J:or Asset Management added most to Eli Lilly in Q2 2026, an estimated $38.6M increase.
  • E. Ohman J:or Asset Management's biggest Q2 2026 reduction was Cboe Global Markets, cutting an estimated $56.7M.
  • E. Ohman J:or Asset Management fully exited Terns Pharmaceuticals in Q2 2026, selling an estimated $1.17M.
  • E. Ohman J:or Asset Management's ten largest holdings make up 43% of its $4.3B portfolio in Q2 2026.
  • E. Ohman J:or Asset Management opened 10 new positions and closed 22 in Q2 2026.
  • E. Ohman J:or Asset Management's portfolio value rose 14% quarter-over-quarter to $4.3B.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.